DrugPatentWatch Database Preview
Details for Patent: 8,026,279
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which drugs does patent 8,026,279 protect, and when does it expire?
Patent 8,026,279 protects HORIZANT and is included in one NDA.
This patent has thirty patent family members in twenty-three countries.
Summary for Patent: 8,026,279
Title: | Crystalline form of .gamma.-aminobutyric acid analog |
Abstract: | A crystalline form of a .gamma.-aminobutyric acid analog, and methods of preparing same, are provided. |
Inventor(s): | Estrada; Tono (Santa Clara, CA), Raillard; Stephen P. (Mountain View, CA) |
Assignee: | XenoPort, Inc. (Santa Clara, CA) |
Application Number: | 10/966,507 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 8,026,279
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-002 | Dec 13, 2011 | RX | Yes | No | Start Trial | Start Trial | Y | Y | Start Trial | |||
Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-001 | Apr 6, 2011 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,026,279
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 516801 | Start Trial | |||
Australia | 2004282192 | Start Trial | |||
Brazil | PI0415288 | Start Trial | |||
Canada | 2541752 | Start Trial | |||
China | 1867322 | Start Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |